126
Views
21
CrossRef citations to date
0
Altmetric
Original Research

A single exposure to iron oxide nanoparticles attenuates antigen-specific antibody production and T-cell reactivity in ovalbumin-sensitized BALB/c mice

, , &
Pages 1229-1235 | Published online: 20 Jun 2011

References

  • LiongMLuJKovochichMMultifunctional inorganic nanoparticles for imaging, targeting, and drug deliveryACS Nano20082588989619206485
  • XieJHuangJLiXSunSChenXIron oxide nanoparticle platform for biomedical applicationsCurr Med Chem200916101278129419355885
  • YuMKJeongYYParkJDrug–loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivoAngew Chem Int Ed Engl200847295362536518551493
  • ChoulyCPouliquenDLucetIJeuneJJJalletPDevelopment of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistributionJ Microencapsul19961332452558860681
  • WangJChenYChenBPharmacokinetic parameters and tissue distribution of magnetic Fe(3)O(4) nanoparticles in miceInt J Nanomedicine2010586186621042548
  • HammBStaksTTaupitzMContrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxideJ Magn Reson Imaging1994456596687981510
  • ReimerPMullerMMarxCT1 effects of a bolus-injectable superparamagnetic iron oxide, SH U 555A: dependence on field strength and plasma concentration–preliminary clinical experience with dynamic T1-weighted MR imagingRadiology199820938318369844683
  • SchipperMLChengZLeeSWmicroPET-based biodistribution of quantum dots in living miceJ Nucl Med20074891511151817704240
  • YamagoSTokuyamaHNakamuraEIn vivo biological behavior of a water-miscible fullerene: 14C labeling, absorption, distribution, excretion and acute toxicityChem Biol1995263853899383440
  • HsiaoJKChuHHWangYHMacrophage physiological function after superparamagnetic iron oxide labelingNMR Biomed200821882082918470957
  • LunovOSyrovetsTBucheleBThe effect of carboxydextran-coated superparamagnetic iron oxide nanoparticles on c-Jun N-terminal kinase-mediated apoptosis in human macrophagesBiomaterials201031195063507120381862
  • ChoWSChoMKimSRPulmonary toxicity and kinetic study of Cy5.5-conjugated superparamagnetic iron oxide nanoparticles by optical imagingToxicol Appl Pharmacol2009239110611519520096
  • ChenBAJinNWangJThe effect of magnetic nanoparticles of Fe(3)O(4) on immune function in normal ICR miceInt J Nanomedicine2010559359920856834
  • DearmanRJCaddickHBasketterDAKimberIDivergent antibody isotype responses induced in mice by systemic exposure to proteins: a comparison of ovalbumin with bovine serum albuminFood Chem Toxicol200038435136010722889
  • VoraKAPorterGPengRGenetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responsesBMC Immunol2009101919358731
  • BeckLSpiegelbergHLThe polyclonal and antigen-specific IgE and IgG subclass response of mice injected with ovalbumin in alum or complete Freund’s adjuvantCell Immunol19891231182776217
  • MorokataTIshikawaJYamadaTAntigen dose defines T helper 1 and T helper 2 responses in the lungs of C57BL/6 and BALB/c mice independently of splenic responsesImmunol Lett200072211912610841947
  • SchatzARKohWSKaminskiNEDelta 9-tetrahydrocannabinol selectively inhibits T-cell dependent humoral immune responses through direct inhibition of accessory T-cell functionImmunopharmacology19932621291378282537
  • JanTRSuSTWuHYLiaoMHSuppressive effects of cannabidiol on antigen-specific antibody production and functional activity of splenocytes in ovalbumin-sensitized BALB/c miceInt Immunopharmacol20077677378017466911
  • MosmannTRapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assaysJ Immunol Methods1983651–255636606682
  • LawaczeckRBauerHFrenzelTMagnetic iron oxide particles coated with carboxydextran for parenteral administration and liver contrasting. Pre-clinical profile of SH U 555AActa Radiol1997384 Pt 15845979240682
  • LeeSMLeeSHKangHYAssessment of musculoskeletal infection in rats to determine usefulness of SPIO-enhanced MRIAJR Am J Roentgenol2007189354254817715098
  • PouliquenDLe JeuneJJPerdrisotRErmiasAJalletPIron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolismMagn Reson Imaging1991932752831881245
  • FerrucciJTStarkDDIron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 yearsAJR Am J Roentgenol199015559439502120963
  • ParkEJKimHKimYYiJChoiKParkKInflammatory responses may be induced by a single intratracheal instillation of iron nanoparticles in miceToxicology20102751–3657120540983
  • YingEHwangHMIn vitro evaluation of the cytotoxicity of iron oxide nanoparticles with different coatings and different sizes in A3 human T lymphocytesSci Total Environ2010408204475448120673962
  • FinkelmanFDHolmesJKatonaIMLymphokine control of in vivo immunoglobulin isotype selectionAnnu Rev Immunol199083033331693082
  • BlankFGerberPRothen-RutishauserBBiomedical nanoparticles modulate specific CD4(+) T cell stimulation by inhibition of antigen processing in dendritic cellsNanotoxicology2011113 [Epub ahead of print].
  • VidardLRockKLBenacerrafBHeterogeneity in antigen processing by different types of antigen-presenting cells. Effect of cell culture on antigen processing abilityJ Immunol19921496190519111517561